MagForce AG, a medical device company, operates in the field of nanotechnology-based cancer treatment in Germany. The company offers NanoTherm therapy that treats solid tumors through the intratumoral generation of heat by activating superparamagnetic nanoparticles. It also provides NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nanopracticles that is activated in an alternating magnetic field; NanoPlan, a treatment planning software; and NanoActivator, a magnetic field applicator for therapy. The company was founded in 1997 and is headquartered in Berlin, Germany.
Market capitalization (30-Oct-2017)
Closing share price (30-Oct-2017)